Prim, S.A. (BME:PRM)

Market Cap	225.43M +22.7%
Revenue (ttm)	251.89M +7.9%
Net Income	16.68M +52.8%
EPS	0.98 +53.1%
Shares Out	17.01M
PE Ratio	13.52
Forward PE	11.46
Dividend	0.47 (3.54%)
Ex-Dividend Date	Mar 10, 2026

Volume	2,474
Open	13.40
Previous Close	13.15
Day's Range	12.95 - 13.40
52-Week Range	11.00 - 13.95
Beta	0.50
Analysts	n/a
Price Target	n/a
Earnings Date	Sep 9, 2026

About Prim, S.A.

Prim, S.A. operates as a health technology, mobility, and health care products provider in Spain. The company offers collar, clavicle, armsling, hand and finger, shoulder, elbow, and wrist products. Its lower limbs products include calf brace, thigh, hip, knee, ankle, and foot related products. The company provides shoulder and back supports, bands, corsets, hyperextension braces, and thoracic protectors under the airtex PRO, bruxi calm, fisionprim, newfeet, ORTHOPrim, PRIM, PRIMcare, respira PLUS, airMed, airtex, aqtivo skin, aqtivo sport, com...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1870
• Employees: 984
• Stock Exchange: Madrid Stock Exchange
• Ticker Symbol: PRM

Financial Performance

In 2025, Prim, S.A.'s revenue was 251.89 million, an increase of 7.94% compared to the previous year's 233.36 million. Earnings were 16.68 million, an increase of 52.77%.